- Home
- ELTX vs RAPT Comparison
ELTX vs RAPT Comparison
Compare ELTX & RAPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ELTX
- RAPT
- Stock Information
- Founded
- ELTX 2011
- RAPT 2015
- Country
- ELTX United States
- RAPT United States
- Employees
- ELTX N/A
- RAPT N/A
- Industry
- ELTX Biotechnology: Pharmaceutical Preparations
- RAPT Biotechnology: Pharmaceutical Preparations
- Sector
- ELTX Health Care
- RAPT Health Care
- Exchange
- ELTX Nasdaq
- RAPT Nasdaq
- Market Cap
- ELTX 54.6M
- RAPT 59.1M
- IPO Year
- ELTX 2021
- RAPT 2019
- Fundamental
- Price
- ELTX $5.80
- RAPT $1.72
- Analyst Decision
- ELTX Strong Buy
- RAPT Hold
- Analyst Count
- ELTX 3
- RAPT 10
- Target Price
- ELTX $9.50
- RAPT $6.00
- AVG Volume (30 Days)
- ELTX 24.0K
- RAPT 8.6M
- Earning Date
- ELTX 11-13-2024
- RAPT 11-12-2024
- Dividend Yield
- ELTX N/A
- RAPT N/A
- EPS Growth
- ELTX N/A
- RAPT N/A
- EPS
- ELTX N/A
- RAPT N/A
- Revenue
- ELTX N/A
- RAPT N/A
- Revenue This Year
- ELTX N/A
- RAPT N/A
- Revenue Next Year
- ELTX N/A
- RAPT N/A
- P/E Ratio
- ELTX N/A
- RAPT N/A
- Revenue Growth
- ELTX N/A
- RAPT N/A
- 52 Week Low
- ELTX $2.96
- RAPT $0.79
- 52 Week High
- ELTX $11.45
- RAPT $27.35
- Technical
- Relative Strength Index (RSI)
- ELTX 64.30
- RAPT 62.07
- Support Level
- ELTX $4.87
- RAPT $1.55
- Resistance Level
- ELTX $5.20
- RAPT $1.79
- Average True Range (ATR)
- ELTX 0.29
- RAPT 0.22
- MACD
- ELTX 0.06
- RAPT 0.08
- Stochastic Oscillator
- ELTX 85.27
- RAPT 60.81
About ELTX Elicio Therapeutics Inc.
Elicio Therapeutics Inc is a clinical-stage biotechnology company pioneering the development of cancer immunotherapies for patients with limited treatment options and poor outcomes. Its proprietary Amphiphile, or AMP, platform delivers investigational immunotherapeutics directly to the brain center of the immune system the lymph nodes. Its focus is the development of cancer immunotherapies against biologically validated but hard-to-drug targets that can be activated through lymph node trafficking. Elicio is engineering lymph node-targeted AMPlifiers, immunomodulators, adjuvants, and vaccines for an array of aggressive cancers. It has developed its cancer vaccine product candidates to target biologically validated tumor mutation drivers using known neoantigens.
About RAPT RAPT Therapeutics Inc.
RAPT Therapeutics Inc is a clinical-stage immunology-based biopharmaceutical company. It is focused on discovering, developing, and commercializing oral small-molecule therapies for patients with some unmet needs in oncology and inflammatory diseases. The company pipeline products include FLX475, designed to selectively inhibit the migration of immunosuppressive regulatory T cells into tumors; and RPT193, designed to selectively inhibit the migration of type 2 T helper cells into inflamed tissues.